The dosage unit sampling apparatus market is projected to grow from USD 3.4 billion in 2025 to USD 7.6 billion by 2035, at a CAGR of 8.3%. Dry Powder Inhalers (DPIs) will dominate with a 55.2% market share, while pharmaceutical companies will lead the end use application segment with a 48.7% share.